Sinead Blaber, Ph.D., Director of Clinical Development and Medical Affairs Paddington, Australia (ASX: RGS) Virtual Presentation Regeneus is a clinical-stage biotech company developing innovative first-in-class stem cell and bioactive therapies that address significant unmet medical needs. Our lead product Progenza™ is a cellular therapy comprised of allogeneic mesenchymal stem...

Matt Klein, M.D., Chief Development Officer South Plainfield, NJ (NASDAQ: PTCT) Virtual Presentation PTC Therapeutics is an industry leader in the discovery, development, and commercialization of medicines for the treatment of rare disorders. For over 20 years, PTC has been pursuing innovative technologies and therapies to develop and provide...

Gregory Block, Ph.D., Senior Vice President, Corporate Development Vancouver, Canada (Private) Virtual Presentation Notch Therapeutics is developing renewable, stem cell-derived immunotherapies, with an initial focus on cancer. We believe that cell therapies can bring value to patients and healthcare systems by being safe, effective, and accessible. www.notchtx.com...

Paulo Garcia, Ph.D., CEO and Co-Founder Cambridge, MA (Private)  Virtual Presentation Kytopen, an MIT spin-out, is a transformative biotechnology company that offers a customizable yet scalable multi-solution platform, which seamlessly links the discovery, development, and manufacturing phases of cell engineering. Flowfect®, a gentle, non-viral delivery method unlocks new therapeutic...

Angela Columbano, Ph.D., Head Business Development and Partnership Paris, France (Private) Virtual Presentation Genethon is developing gene therapy products for rare diseases with a focus on muscular diseases such as dystrophies and myopathies, as well as liver and metabolism related diseases. www.genethon.fr...

Mike Graffeo, CEO Action, MA (Private) Virtual Presentation  FluidForm is transforming medicine by creating human tissue for drug discovery, surgical repair, and organ transplant. By integrating 3D printing, computational and synthetic biology, AI and machine learning, and advanced materials science, we are developing human tissue applications that deliver on...

Laurence Reid, Ph.D., CEO  Boston, MA (NASDAQ: DBTX) Virtual Presentation Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine. Decibel has built a proprietary platform that integrates...

Cindy Ru, Ph.D., Managing Director San Diego, CA (Private) Virtual Presentation CRC Oncology is a contract research organization (CRO) focused on reshaping the global landscape of innovative drugs and therapies for cancer treatment, especially in the field of advanced cell and gene therapy. CRC Oncology provides high quality development...

Jeff Gilmore, President Longmont, CO (Private) Virtual Presentation cGMPnow accelerates cell and gene therapy products to patients by providing turnkey GMP manufacturing equipment, automation and controls (IT/OT), commissioning and qualification, and procurement services. We provide a faster path to GMP readiness via a streamlined delivery of fully-validated GMP equipment,...

Shin Hatou, M.D., Ph.D., CEO Tokyo, Japan (Private) Virtual Presentation Cellusion is a regenerative medicine startup founded by three professors at Keio University School of Medicine, Department of Ophthalmology in Japan. Cellusion has several unique technologies including a highly efficient direct differentiation induction method to produce corneal endothelial substituted...

By using this website you agree to accept our Privacy Policy and Terms & Conditions